What is the significance of a ferritin level of 528 ng/mL and how should it be evaluated and managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ferritin 528 ng/mL: Evaluation and Management

A ferritin level of 528 ng/mL is moderately elevated and requires immediate evaluation with transferrin saturation (TS) to distinguish between true iron overload and secondary causes such as inflammation, liver disease, or metabolic conditions.

Initial Diagnostic Approach

The first critical step is to measure transferrin saturation alongside ferritin rather than relying on ferritin alone 1. This combination is essential because ferritin is an acute-phase reactant that elevates with inflammation, infection, liver disease (alcoholic liver disease, chronic hepatitis B/C, NAFLD), lymphomas, and other chronic inflammatory conditions—in fact, iron overload is NOT the most common cause of elevated ferritin in the general population 1.

Key Interpretation Framework:

  • If TS ≥ 45%: Proceed to HFE genetic testing (C282Y and H63D mutations) to evaluate for hereditary hemochromatosis 1
  • If TS < 45%: The elevated ferritin is likely secondary to inflammation or other non-iron overload causes 1

Risk Stratification Based on Ferritin Level

At 528 ng/mL, this ferritin level falls below the critical 1000 μg/L threshold, which has important prognostic implications:

  • Ferritin <1000 μg/L is an accurate predictor for the absence of cirrhosis in hemochromatosis patients 1
  • If this patient has confirmed C282Y homozygosity with ferritin <1000 μg/L and normal liver enzymes (ALT, AST), they can proceed directly to therapeutic phlebotomy without liver biopsy 1
  • Ferritin >1000 μg/L combined with elevated aminotransferases (ALT or AST) and platelet count <200 predicts cirrhosis in 80% of C282Y homozygotes 1

Differential Diagnosis to Exclude

Before attributing this to iron overload, systematically evaluate:

  1. Inflammatory conditions: Check CRP, ESR to identify active inflammation 1, 2
  2. Liver disease: Measure ALT, AST, alkaline phosphatase—ferritin elevates in alcoholic liver disease, chronic hepatitis B/C, and NAFLD 1
  3. Metabolic syndrome: Assess for obesity, insulin resistance, diabetes 3
  4. Malignancy: Consider lymphoma and other malignancies 1
  5. Chronic kidney disease: Ferritin interpretation differs in CKD patients 4, 2

Common Pitfall:

Do NOT assume elevated ferritin automatically means iron overload—this is the most frequent diagnostic error. The absence of elevated TS makes true iron overload unlikely 1.

Management Algorithm

If Hemochromatosis is Confirmed (C282Y homozygote with TS ≥45%):

Initiate weekly therapeutic phlebotomy (500 mL blood removal) with the following protocol 1:

  • Check hemoglobin/hematocrit before each phlebotomy
  • Allow hemoglobin to fall by no more than 20% from baseline
  • Monitor ferritin every 10-12 phlebotomies
  • Target ferritin: 50-100 μg/L (this is the evidence-based endpoint) 1, 5
  • Once target achieved, continue maintenance phlebotomy every 3-6 months to keep ferritin 50-100 μg/L 1, 5

Dietary modifications during treatment 1:

  • Avoid vitamin C supplements (increases iron absorption)
  • Avoid iron supplements and iron-fortified foods
  • Avoid raw shellfish (risk of Vibrio vulnificus infection in iron overload)
  • Otherwise, maintain a normal healthy diet—no special restrictions needed

If Secondary Iron Overload (non-HFE):

For conditions like NAFLD with secondary iron elevation, phlebotomy has shown benefit with improvement in insulin resistance parameters and ALT reduction 1. However, phlebotomy is NOT recommended for mild secondary iron overload (hepatic iron concentration <2500 μg/g dry weight) in chronic hepatitis C 1.

If Inflammatory/Non-Iron Overload Cause:

Address the underlying condition causing ferritin elevation rather than treating the ferritin itself. Serial monitoring may be appropriate, but iron removal therapy is not indicated.

Monitoring Strategy

  • Repeat ferritin with TS to confirm the elevation and assess trends
  • If proceeding with phlebotomy, ferritin should be checked every 10-12 sessions initially 1
  • As ferritin approaches normal range, increase monitoring frequency 5

Important Caveat:

Ferritin measurements can vary significantly between different laboratory assays (up to 150 ng/mL difference) 6, 7. Use the same laboratory method for serial measurements to ensure consistency.

When to Consider Liver Biopsy

Liver biopsy for hepatic iron concentration and histopathology is indicated when 1:

  • Ferritin >1000 μg/L with elevated liver enzymes
  • Compound heterozygote (C282Y/H63D) with ferritin >1000 μg/L
  • Non-C282Y genotype with elevated ferritin and liver enzyme abnormalities
  • Need to assess for cirrhosis or other liver pathology

At ferritin 528 ng/mL with normal liver enzymes, liver biopsy is NOT required if genetic testing confirms C282Y homozygosity 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.